Dong Li1, Elizabeth A Streeten2,3,4, Alice Chan5, Wint Lwin6,7, Lifeng Tian1, Renata Pellegrino da Silva1, Cecilia E Kim1, Mark S Anderson6,7, Hakon Hakonarson1,8, Michael A Levine9,8. 1. Center for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104. 2. Division of Endocrinology, University of Maryland School of Medicine, Baltimore, Maryland 21201. 3. Division of Diabetes, University of Maryland School of Medicine, Baltimore, Maryland 21201. 4. Division of Nutrition and Genetics, University of Maryland School of Medicine, Baltimore, Maryland 21201. 5. Department of Pediatrics, University of California-San Francisco, San Francisco, California 94143. 6. Diabetes Center, University of California-San Francisco, San Francisco, California 94143. 7. Department of Medicine, University of California-San Francisco, San Francisco, California 94143. 8. Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104. 9. Division of Endocrinology and Diabetes, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104.
Abstract
Context: Most cases of autosomal recessive hypoparathyroidism (HYPO) are caused by loss-of-function mutations in GCM2 or PTH. Objective: The objective of this study was to identify the underlying genetic basis for isolated HYPO in a kindred in which 3 of 10 siblings were affected. Subjects: We studied the parents and the three adult affected subjects, each of whom was diagnosed with HYPO in the first decade of life. Methods: We collected clinical and biochemical data and performed whole exome sequencing analysis on DNA from the three affected subjects after negative genetic testing for known causes of HYPO. Results: Whole exome sequencing followed by Sanger sequencing revealed that all three affected subjects were compound heterozygous for two previously reported mutations, c.967_979delCTGTCCCCTCCGC:p.(L323SfsX51) and c.995+(3_5)delGAGinsTAT, in AIRE, which encodes the autoimmune regulator protein that is defective in autoimmune polyglandular syndrome type 1 (APS-1). Each parent carries one mutation, and all of the children of the patients are either heterozygous for one mutation or wild type. The affected sister developed premature ovarian failure, but the two affected brothers have no other features of APS-1 despite elevated serum levels of anti-interferon-α antibodies. Conclusions: Our findings indicate that biallelic mutations in AIRE can cause isolated HYPO as well as syndromic APS-1. The presence of antibodies to interferon-α provides a highly sensitive indicator for loss of AIRE function and represents a useful marker for isolated HYPO due to AIRE mutations.
Context: Most cases of autosomal recessive hypoparathyroidism (HYPO) are caused by loss-of-function mutations in GCM2 or PTH. Objective: The objective of this study was to identify the underlying genetic basis for isolated HYPO in a kindred in which 3 of 10 siblings were affected. Subjects: We studied the parents and the three adult affected subjects, each of whom was diagnosed with HYPO in the first decade of life. Methods: We collected clinical and biochemical data and performed whole exome sequencing analysis on DNA from the three affected subjects after negative genetic testing for known causes of HYPO. Results: Whole exome sequencing followed by Sanger sequencing revealed that all three affected subjects were compound heterozygous for two previously reported mutations, c.967_979delCTGTCCCCTCCGC:p.(L323SfsX51) and c.995+(3_5)delGAGinsTAT, in AIRE, which encodes the autoimmune regulator protein that is defective in autoimmune polyglandular syndrome type 1 (APS-1). Each parent carries one mutation, and all of the children of the patients are either heterozygous for one mutation or wild type. The affected sister developed premature ovarian failure, but the two affected brothers have no other features of APS-1 despite elevated serum levels of anti-interferon-α antibodies. Conclusions: Our findings indicate that biallelic mutations in AIRE can cause isolated HYPO as well as syndromic APS-1. The presence of antibodies to interferon-α provides a highly sensitive indicator for loss of AIRE function and represents a useful marker for isolated HYPO due to AIRE mutations.
Authors: Michael Mannstadt; Mark Harris; Bert Bravenboer; Sridhar Chitturi; Koen M A Dreijerink; David G Lambright; Elaine T Lim; Mark J Daly; Stacey Gabriel; Harald Jüppner Journal: N Engl J Med Date: 2013-06-27 Impact factor: 91.245
Authors: Sihoon Lee; Michael Mannstadt; Jun Guo; Seul Min Kim; Hyon-Seung Yi; Ashok Khatri; Thomas Dean; Makoto Okazaki; Thomas J Gardella; Harald Jüppner Journal: J Bone Miner Res Date: 2015-06-08 Impact factor: 6.741
Authors: Ruti Parvari; Eli Hershkovitz; Nili Grossman; Rafael Gorodischer; Bart Loeys; Alexandra Zecic; Geert Mortier; Simon Gregory; Reuven Sharony; Marios Kambouris; Nadia Sakati; Brian F Meyer; Aida I Al Aqeel; Abdul Karim Al Humaidan; Fatma Al Zanhrani; Abdulrahman Al Swaid; Johara Al Othman; George A Diaz; Rory Weiner; K Tahseen S Khan; Ronald Gordon; Bruce D Gelb Journal: Nat Genet Date: 2002-10-21 Impact factor: 38.330
Authors: K Nagamine; P Peterson; H S Scott; J Kudoh; S Minoshima; M Heino; K J Krohn; M D Lalioti; P E Mullis; S E Antonarakis; K Kawasaki; S Asakawa; F Ito; N Shimizu Journal: Nat Genet Date: 1997-12 Impact factor: 38.330
Authors: Mohammad Alimohammadi; Peyman Björklund; Asa Hallgren; Nora Pöntynen; Gabor Szinnai; Noriko Shikama; Marcel P Keller; Olov Ekwall; Sarah A Kinkel; Eystein S Husebye; Jan Gustafsson; Fredrik Rorsman; Leena Peltonen; Corrado Betterle; Jaakko Perheentupa; Göran Akerström; Gunnar Westin; Hamish S Scott; Georg A Holländer; Olle Kämpe Journal: N Engl J Med Date: 2008-03-06 Impact factor: 91.245
Authors: Anthony Meager; Kumuthini Visvalingam; Pärt Peterson; Kaidi Möll; Astrid Murumägi; Kai Krohn; Petra Eskelin; Jaakko Perheentupa; Eystein Husebye; Yoshihisa Kadota; Nick Willcox Journal: PLoS Med Date: 2006-07 Impact factor: 11.069